Tilray, Inc. (TLRY) Reports Q1 EPS of $0.18

Go back to Tilray, Inc. (TLRY) Reports Q1 EPS of $0.18

Tilray, Inc. Reports 2021 Fiscal Year and Fourth Quarter Results

July 28, 2021 7:00 AM EDT

Net Revenue Increased 27% to $513 Million Compared to Prior Year

Net Income of $33.6 Million, Adjusted EBITDA of $12.3 Million, Net Cash from Operating Activities of $8.3 Million and Positive Free Cash Flow of $3.3 Million in Q4

Completed Business Combination with Aphria Inc., Achieved $35 Million in Synergies To Date; On-track for $80 Million Target

Cannabis Revenue Grew 55% in Q4, #1 Market Share in Canada

Leading EU GMP-Certified Medical Cannabis LP in Europe with Demand Growing

Executive Leadership... More